BioTime is building a dominant company in the field of regenerative medicine. Our strategy is to be the leader in the development of pluripotent stem cell-based technologies and to apply those new technologies in the treatment of degenerative diseases that afflict large numbers of people worldwide. We have advanced additional products into human clinical trials over the past year.
We are committed to leading the regenerative medicine revolution to realize the promise of our revolutionary therapies. By advancing the development of our clinical products and technologies, our goal is to find cures for serious degenerative diseases that afflict people worldwide. Through the commitment from our family of companies and our dedicated scientists and employees, we are working to bring revolutionary new regenerative medicines to patients with chronic and degenerative diseases.
Asterias Biotherapeutics Added To Russell 2000®, Russell 3000®, Russell Global and Russell Microcap® IndexesJune 30 2015 10:30 AM
- June 16 2015 12:30 PM
Preliminary Reconstitutions of Russell 3000®, Russell Global and Russell Microcap® Indexes Include Asterias BiotherapeuticsJune 15 2015 1:01 PM